<DOC>
	<DOCNO>NCT02948257</DOCNO>
	<brief_summary>The objective registry collect procedural outcome data Cardiva VASCADE Vascular Closure System ( VCS ) use seal femoral arterial access site completion ipsilateral peripheral interventional procedure perform 5-7F introducer sheath via antegrade approach .</brief_summary>
	<brief_title>VASCADE ANTEGRADE-PVD Post-Market Registry</brief_title>
	<detailed_description>Due grow adoption antegrade femoral access use VCDs close arteriotomies , important collect performance complication outcome data related procedural variable . The aim registry consistently collect prospective data procedural outcome antegrade access case close VASCADE VCS way consistent RESPECT Study design FDA-approved Instructions Use ( IFU ) .</detailed_description>
	<criteria>Acceptable candidate postprocedural manual compression Able ambulate least 20 foot , without assistance Active systemic cutaneous infection inflammation Ipsilateral femoral arteriotomy follow condition : ) access within &lt; = 10 day ; b ) residual hematoma , significant bruising , know associated vascular complication ; c ) within &lt; = 90 day , use intravascular closure device ( i.e. , Angioseal ) Previous vascular graft surgery target vessel access site Major amputation ipsilateral low extremity previous history , plan within next 30 day prior study exit Extreme morbid obesity ( BMI great 4 kg/m2 ) underweight ( BMI le 20 kg/m2 ) Femoral arterial diameter &lt; 6 mm access site Antegrade arterial access site side stick and/or single anterior wall femoral puncture Length tissue tract , distance anterior arterial wall skin , &lt; 2.5 cm .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Vessel closure</keyword>
	<keyword>Antegrade access</keyword>
	<keyword>Femoral arteriotomy</keyword>
	<keyword>Peripheral endovascular intervention</keyword>
</DOC>